$47.99 $0.71 (1.5%)

01:17 PM EDT on 06/02/20

Biotelemetry, Inc. (NASDAQ:BEAT)

CAPS Rating: 4 out of 5

Current Price $47.99 Mkt Cap $1.6B
Open $47.35 P/E Ratio 63.77
Prev. Close $47.28 Div. (Yield) $0.00 (0.0%)
Daily Range $46.62 - $48.08 Volume 49,950
52-Wk Range $27.35 - $55.85 Avg. Daily Vol. 321,517

Caps

How do you think NASDAQ:BEAT will perform against the market?

Add Stock to CAPS Watchlist

All Players

200 Outperform
24 Underperform
 

All-Star Players

28 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:BEAT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFTypeoh (95.80)
Submitted October 05, 2016

+Growing revenue and profits at double digits+Growth should continue thanks to international expansion, new products, and broader coverage+Possibly entering prenatal market down the road+Solid performance year to date

berrygeorge (20.03)
Submitted November 12, 2009

This company is unable to collect their bills and has recently rebilled all their customers. Look at their web site. This is a relatively new company with a good concept but no one wants to pay for it.No end in sight. Will drop before it goes up.

Recent Community Commentary

Read the most recent pitches from players about BEAT.

Recs

0
Member Avatar TMFEBCapital (94.40) Submitted: 5/4/2017 1:39:55 PM : Outperform Start Price: $28.20 NASDAQ:BEAT Score: +40.50

Demand for mobile cardiac monitoring will grow as baby boomers get older and the prevalence of diseases that cause cardiac complications increases. The company is still growing double digits YoY, and EPS was in line with estimates. Using today's post-EPS drop as an opp to stash this stock away.

Recs

0
Member Avatar captainccs (46.48) Submitted: 4/27/2017 6:00:52 PM : Outperform Start Price: $32.65 NASDAQ:BEAT Score: +17.74

Biotelemetry is at the crossroads between healthcare and IoT and it is consolidating its position as industry leader with timely acquisitions.

Recs

1
Member Avatar TMFTypeoh (95.80) Submitted: 10/5/2016 11:32:40 AM : Outperform Start Price: $21.22 NASDAQ:BEAT Score: +82.60

+Growing revenue and profits at double digits
+Growth should continue thanks to international expansion, new products, and broader coverage
+Possibly entering prenatal market down the road
+Solid performance year to date

Leaderboard

Find the members with the highest scoring picks in BEAT.

Score Leader

GCshipbuilder

GCshipbuilder (< 20) Score: +851.63

The Score Leader is the player with the highest score across all their picks in BEAT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
GCshipbuilder < 20 9/22/2010 Outperform 1Y $4.25 +1,021.65% +170.01% +851.63 1 Comment
aelenon 25.58 12/4/2009 Outperform 5Y $4.29 +1,011.19% +177.14% +834.05 0 Comment
Terapixel 95.67 11/19/2010 Outperform 5Y $4.40 +983.41% +155.32% +828.09 0 Comment
T206 70.18 6/11/2013 Outperform 5Y $4.72 +909.96% +87.20% +822.76 0 Comment
gaiachild 22.83 9/17/2010 Outperform 5Y $4.37 +990.85% +171.06% +819.78 0 Comment
50daybelowclose < 20 7/7/2010 Outperform 5Y $4.31 +1,006.03% +193.81% +812.23 0 Comment
frederick7 < 20 4/7/2011 Outperform 3Y $4.68 +918.59% +129.73% +788.86 0 Comment
Soberstocks 72.45 4/7/2011 Outperform 5Y $4.70 +914.23% +130.00% +784.23 0 Comment
a2raya1983 52.69 11/15/2010 Outperform 5Y $4.64 +927.37% +153.73% +773.64 0 Comment
nick0630 < 20 3/29/2011 Outperform 3Y $4.75 +903.58% +134.13% +769.45 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BEAT.